PFE.F
Pfizer Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
24.10
▲ 0.39 (1.64%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
23.71
Prev close
23.71
Day high
24.30
Day low
23.67
Volume
9.01K
Market cap
$137.36B
P/E (TTM)
37.08
52W range
20.13 – 24.86
Day trading desk
Gap from prior close
0.00%
Prior close 23.71
VWAP
24.00
+0.44% from price
Relative volume
2.27×
Unusually busy
Session range
2.66%
23.67 – 24.30
Position in range
68%
Mid range
ATR (14D)
0.47
1.97% of price
Prior day high
24.22
PDH
Prior day low
23.71
PDL
Bid / ask spread
—
Quote not published
Session volume
17.79K
Avg 7.83K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.22%
+5.6%
1M
+9.57%
+5.8%
3M
+8.93%
+5.8%
6M
+5.06%
-6.0%
YTD
+13.33%
+1.0%
1Y
+9.70%
-10.3%
3Y
-27.41%
-101.6%
5Y
-37.76%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PFE.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.76M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 12, 26 | BOURLA ALBERT Chief Executive Officer |
BUY | 38.00K | $1.00M | Direct |
| Aug 5, 26 | DAMICO JENNIFER B. Officer |
SELL | 3.28K | $83.26K | Direct |
| Aug 5, 26 | BLAYLOCK RONALD E Director |
BUY | 39.23K | $998.82K | Direct |
| Aug 5, 26 | BUCKLEY MORTIMER J. Director |
BUY | 37.63K | $960.37K | Direct |
| Jun 9, 26 | DAMICO JENNIFER B. Officer |
SELL | 2.00K | $51.40K | Direct |
| Mar 3, 26 | DAMICO JENNIFER B. Officer |
STOCK | 21.72K | $0 | Direct |
| Feb 25, 26 | BOURLA ALBERT Chief Executive Officer |
CONVERSION | 491.63K | $16.63M | Direct |
| Feb 25, 26 | LANKLER DOUGLAS M Officer |
CONVERSION | 122.91K | $4.16M | Direct |
| Feb 25, 26 | SAHNI PAYAL Officer |
CONVERSION | 56.89K | $1.92M | Direct |
| Feb 25, 26 | MCDERMOTT MICHAEL Officer |
CONVERSION | 37.92K | $1.28M | Direct |
| Feb 25, 26 | DAMICO JENNIFER B. Officer |
CONVERSION | 17.56K | $593.81K | Direct |
| Feb 25, 26 | FONSECA LIDIA PH.D. Officer |
CONVERSION | 56.89K | $1.92M | Direct |
| Feb 25, 26 | BOSHOFF CHRISTOFFEL Officer |
STOCK | 13.38K | $0 | Direct |
| Mar 4, 25 | DAMICO JENNIFER B. Officer |
SELL | 2.50K | $64.83K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BLAYLOCK RONALD E |
Director | 71.69K | Purchase |
BOSHOFF CHRISTOFFEL |
Officer | 162.09K | Stock Award(Grant) |
BOURLA ALBERT |
Chief Executive Officer | 435.56K | Purchase |
BUCKLEY MORTIMER J. |
Director | 37.63K | Purchase |
DAMICO JENNIFER B. |
Officer | 28.61K | Sale |
FONSECA LIDIA PH.D. |
Officer | 46.45K | Conversion of Exercise of derivative security |
LANKLER DOUGLAS M |
Officer | 165.26K | Conversion of Exercise of derivative security |
MCDERMOTT MICHAEL |
Officer | 74.31K | Conversion of Exercise of derivative security |
SAHNI PAYAL |
Officer | 42.30K | Conversion of Exercise of derivative security |
SUSMAN SALLY |
Officer | 169.78K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$137.36B
Enterprise value$189.44B
Revenue (TTM)$63.70B
Gross profit$47.59B
EBITDA$25.38B
Net income$4.34B
EPS (TTM)$0.65
Free cash flow$12.49B
Total cash$11.70B
Total debt$63.48B
Book value / share$12.81
Shares outstanding5.70B
Float5.69B
Short % of float—
Dividend yield6.27%
Beta (5Y)0.28
Valuation & profitability ratios
Trailing P/E37.08
Forward P/E—
PEG ratio2.73
Price / sales—
Price / book1.88
EV / revenue2.97
EV / EBITDA7.46
Gross margin74.72%
Operating margin27.88%
Profit margin6.80%
Return on equity5.01%
Return on assets5.78%
Debt / equity74.25
Current ratio1.27
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $62.58B | $63.63B | $59.55B | $101.17B | -1.6% |
| Operating revenue | $62.58B | $63.63B | $59.55B | $101.17B | -1.6% |
| Cost of revenue | $16.07B | $17.85B | $24.95B | $34.34B | -10.0% |
| Gross profit | $46.51B | $45.78B | $34.60B | $66.83B | +1.6% |
| Research & development | $10.44B | $10.82B | $10.68B | $11.43B | -3.6% |
| Selling, general & admin | $13.79B | $14.73B | $14.77B | $13.68B | -6.4% |
| Total operating expense | $29.11B | $30.84B | $30.18B | $28.71B | -5.6% |
| Operating income | $17.41B | $14.94B | $4.42B | $38.12B | +16.5% |
| Net interest income | -$2.07B | -$2.55B | -$585.00M | -$987.00M | +18.8% |
| Pre-tax income | $7.52B | $8.02B | $1.06B | $34.73B | -6.3% |
| Tax provision | -$266.00M | -$28.00M | -$1.11B | $3.33B | -850.0% |
| Net income | $7.77B | $8.03B | $2.12B | $31.37B | -3.2% |
| Net income to common | $7.77B | $8.03B | $2.12B | $31.37B | -3.2% |
| Basic EPS | 1.37 | 1.42 | 0.38 | 5.59 | -3.5% |
| Diluted EPS | 1.36 | 1.41 | 0.37 | 5.47 | -3.5% |
| EBIT | $10.19B | $11.11B | $3.27B | $35.97B | -8.3% |
| EBITDA | $16.78B | $18.13B | $9.56B | $41.03B | -7.4% |
| Basic shares | 5.68B | 5.66B | 5.64B | 5.61B | +0.3% |
| Diluted shares | 5.71B | 5.70B | 5.71B | 5.73B | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.14B | $1.04B | $2.85B | $416.00M | +9.5% |
| Cash & short-term investments | $13.60B | $20.48B | $12.69B | $22.73B | -33.6% |
| Accounts receivable | $11.87B | $11.46B | $11.57B | $10.95B | +3.6% |
| Inventory | $10.65B | $10.85B | $10.19B | $8.98B | -1.8% |
| Total current assets | $42.90B | $50.36B | $43.33B | $51.26B | -14.8% |
| Property, plant & equipment | $19.32B | $18.39B | $18.94B | $16.27B | +5.0% |
| Goodwill & intangibles | $124.99B | $123.94B | $132.68B | $94.75B | +0.9% |
| Total assets | $208.16B | $213.40B | $226.50B | $197.21B | -2.5% |
| Total current liabilities | $36.98B | $42.99B | $47.79B | $42.14B | -14.0% |
| Current debt | $3.15B | $6.95B | $10.35B | $2.93B | -54.6% |
| Long-term debt | $60.81B | $56.70B | $60.50B | $31.93B | +7.2% |
| Total debt | $63.96B | $63.65B | $70.84B | $34.86B | +0.5% |
| Total liabilities | $121.39B | $124.90B | $137.21B | $101.29B | -2.8% |
| Retained earnings | $114.61B | $116.72B | $118.35B | $125.66B | -1.8% |
| Shareholder equity | $86.48B | $88.20B | $89.01B | $95.66B | -2.0% |
| Working capital | $5.91B | $7.36B | -$4.46B | $9.12B | -19.7% |
| Net tangible assets | -$38.52B | -$35.74B | -$43.67B | $916.00M | -7.8% |
| Shares issued | 9.62B | 9.59B | 9.56B | 9.52B | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $7.79B | $8.05B | $2.17B | $31.40B | — | -3.3% |
| Depreciation & amortisation | $6.59B | $7.01B | $6.29B | $5.06B | — | -6.0% |
| Stock-based compensation | $799.00M | $877.00M | $525.00M | $872.00M | — | -8.9% |
| Change in working capital | -$5.35B | -$3.07B | -$2.17B | -$5.64B | — | -74.6% |
| Operating cash flow | $11.70B | $12.74B | $8.70B | $29.27B | — | -8.2% |
| Capital expenditure | -$2.63B | -$2.91B | -$3.91B | -$3.24B | — | +9.6% |
| Investing cash flow | -$1.35B | $2.65B | -$32.28B | -$15.78B | — | -150.9% |
| Share buybacks | — | $0 | $0 | -$2.00B | $0 | — |
| Dividends paid | -$9.77B | -$9.51B | -$9.25B | -$8.98B | — | -2.7% |
| Financing cash flow | -$10.30B | -$17.14B | $26.07B | -$14.83B | — | +39.9% |
| Free cash flow | $9.07B | $9.84B | $4.79B | $26.03B | — | -7.7% |
| End cash position | $1.20B | $1.11B | $2.92B | $468.00M | — | +8.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $15.03B | $14.45B | $17.56B | $16.65B | $14.65B | — | +4.0% |
| Operating revenue | $15.03B | $14.45B | $17.56B | $16.65B | $14.65B | — | +4.0% |
| Cost of revenue | $4.09B | $3.55B | $5.27B | $4.17B | $3.78B | — | +15.3% |
| Gross profit | $10.94B | $10.90B | $12.29B | $12.48B | $10.88B | — | +0.4% |
| Research & development | $2.81B | $2.49B | $3.21B | $2.55B | $2.48B | — | +12.8% |
| Selling, general & admin | $3.41B | $2.96B | $4.16B | $3.19B | $3.42B | — | +15.2% |
| Total operating expense | $7.41B | $6.63B | $8.60B | $6.96B | $7.11B | — | +11.6% |
| Operating income | $3.54B | $4.27B | $3.69B | $5.53B | $3.77B | — | -17.1% |
| Net interest income | -$554.00M | -$553.00M | -$545.00M | -$514.00M | -$498.00M | — | -0.2% |
| Pre-tax income | -$653.00M | $3.17B | -$1.64B | $3.33B | $3.04B | — | -120.6% |
| Tax provision | -$407.00M | $461.00M | -$2.00M | -$216.00M | $141.00M | — | -188.3% |
| Net income | -$248.00M | $2.69B | -$1.65B | $3.54B | $2.91B | — | -109.2% |
| Net income to common | -$248.00M | $2.69B | -$1.65B | $3.54B | $2.91B | — | -109.2% |
| Basic EPS | -0.04 | 0.47 | -0.29 | — | 0.51 | 0.52 | -108.5% |
| Diluted EPS | -0.04 | 0.47 | -0.29 | — | 0.51 | 0.52 | -108.5% |
| EBIT | $14.00M | $3.84B | -$931.00M | $3.99B | $3.70B | — | -99.6% |
| EBITDA | $1.64B | $5.45B | $756.00M | $5.65B | $5.32B | — | -70.0% |
| Basic shares | 5.70B | 5.69B | 5.69B | — | 5.68B | 5.67B | +0.1% |
| Diluted shares | 5.70B | 5.73B | 5.69B | — | 5.71B | 5.71B | -0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $976.00M | $1.70B | $1.14B | $1.34B | $1.64B | -42.7% |
| Cash & short-term investments | $11.70B | $13.07B | $13.60B | $14.98B | $13.25B | -10.5% |
| Accounts receivable | $12.49B | $12.59B | $11.87B | $14.26B | $12.08B | -0.8% |
| Inventory | $9.95B | $10.67B | $10.65B | $11.47B | $11.67B | -6.8% |
| Total current assets | $41.36B | $42.82B | $42.90B | $46.92B | $43.70B | -3.4% |
| Property, plant & equipment | $19.03B | $19.40B | $19.32B | $18.88B | $18.78B | -1.9% |
| Goodwill & intangibles | $118.47B | $123.97B | $124.99B | $120.42B | $121.70B | -4.4% |
| Total assets | $201.13B | $207.62B | $208.16B | $208.73B | $206.09B | -3.1% |
| Total current liabilities | $32.65B | $34.35B | $36.98B | $36.60B | $37.73B | -5.0% |
| Current debt | $2.70B | $3.89B | $3.15B | $4.30B | $4.30B | -30.6% |
| Long-term debt | $60.49B | $59.84B | $60.81B | $56.55B | $56.63B | +1.1% |
| Total debt | $63.19B | $63.73B | $63.96B | $60.85B | $60.93B | -0.8% |
| Total liabilities | $115.64B | $117.21B | $121.39B | $115.64B | $117.08B | -1.3% |
| Retained earnings | $112.09B | $117.24B | $114.61B | $121.15B | $117.61B | -4.4% |
| Shareholder equity | $85.19B | $90.10B | $86.48B | $92.80B | $88.69B | -5.5% |
| Working capital | $8.71B | $8.47B | $5.91B | $10.33B | $5.98B | +2.8% |
| Net tangible assets | -$33.28B | -$33.87B | -$38.52B | -$27.62B | -$33.01B | +1.7% |
| Shares issued | 5.70B | 9.64B | 9.62B | 9.62B | 9.62B | -40.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$220.00M | $2.68B | -$1.64B | $3.55B | $2.90B | -108.2% |
| Depreciation & amortisation | $1.62B | $1.61B | $1.69B | $1.66B | $1.63B | +0.6% |
| Stock-based compensation | $249.00M | $272.00M | $225.00M | $201.00M | $203.00M | -8.5% |
| Change in working capital | -$1.82B | -$1.73B | $1.59B | -$36.00M | -$4.99B | -4.8% |
| Operating cash flow | $835.00M | $2.62B | $5.35B | $4.60B | -$582.00M | -68.1% |
| Capital expenditure | -$533.00M | -$436.00M | -$845.00M | -$602.00M | -$618.00M | -22.2% |
| Investing cash flow | $2.11B | $785.00M | -$6.15B | -$2.43B | $3.95B | +168.3% |
| Dividends paid | -$2.45B | -$2.44B | -$2.44B | -$2.44B | -$2.44B | -0.2% |
| Financing cash flow | -$3.66B | -$2.86B | $596.00M | -$2.48B | -$3.20B | -28.3% |
| Free cash flow | $302.00M | $2.18B | $4.50B | $4.00B | -$1.20B | -86.1% |
| End cash position | $1.03B | $1.76B | $1.20B | $1.39B | $1.69B | -41.3% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $15.95B | -4.2% |
| Next quarter | — | — | $16.87B | -3.9% |
| Current year | — | — | $62.24B | -0.5% |
| Next year | — | — | $59.84B | -3.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.10%
Held by institutions69.13%
Institutions holding3.65K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
23.45
+2.78% from price
SMA 20
22.75
+5.94% from price
SMA 50
22.04
+9.32% from price
SMA 100
22.33
+7.91% from price
SMA 200
22.36
+7.77% from price
EMA 12
23.33
+3.29% from price
EMA 26
22.78
+5.81% from price
EMA 50
22.44
+7.39% from price
RSI (14)
66.7
Neutral
MACD (12,26,9)
0.56
Hist 0.13
ATR (14)
0.47
1.97% of price
Realised vol 30D
21.7%
Annualised
Bollinger upper
24.39
20, 2σ
Bollinger lower
21.11
20, 2σ
50 / 200 cross
Death
22.04 vs 22.36
Trend bias
Above 200
+7.77%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.07
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
21.7%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-15.8%
Peak to trough
Max drawdown 5Y
-64.4%
Peak to trough
ATR 14
0.47
1.97% of price
Beta (reported)
0.28
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 13, 26 | BMO Capital | MAINTAINED | Outperform | Outperform |
| Jul 13, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 10, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Jul 8, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Jul 6, 26 | Cantor Fitzgerald | MAINTAINED | Neutral | Neutral |
| Jul 6, 26 | HSBC | DOWNGRADE | Buy | Hold |
| Jun 10, 26 | RBC Capital | UPGRADE | Underperform | Sector Perform |
| Apr 29, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Apr 20, 26 | RBC Capital | MAINTAINED | Underperform | Underperform |
| Apr 16, 26 | CICC | INITIATED | — | Outperform |
| Apr 13, 26 | UBS | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate$1.51 / yr
Forward yield6.27%
5-year avg yield5.07%
Payout ratio226.32%
Ex-dividend dateJul 24, 2026
Next pay date—
Last split—
Split date—
Headlines
Raphinha, Lopez hit braces as Barcelona trounce Elche
AFP · 12m ago
Amorim starts Serie A life with Milan win, Juve edge Frosinone
AFP · 15m ago
Lawsuit filed in Napali coast ‘doors-off’ helicopter tour crash
The Honolulu Star-Advertiser · 15m ago
Does Billionaire Bill Ackman Know Something Wall Street Doesn’t? He Invested in These 2 Stocks That Have Dropped 33% and 18% Over the Past Year
Motley Fool · 16m ago
Liquor industry struggles grow with another Chapter 7 filing
TheStreet · 18m ago
Media Advisory: Housing Announcement in Toronto
CNW Group · 21m ago
Dow Jones Futures Due With Market At Key Point; Nvidia, Tariffs, Warsh In Focus
Investor's Business Daily · 28m ago
Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Motley Fool · 31m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.